Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert Kazemier

Showing results (141-150 of 298) with videos related to

Pageof 30
Sort By:
Journal of Patient-Reported Outcomes|December 9, 2022
Development of a set of patient reported outcome measures for patients with benign liver tumours and cysts: patient focus groups and systematic reviewAlicia Furumaya, Lynn E Nooijen, Martijn P D Haring, et al.
Cancers|October 23, 2021
Artificial Intelligence-Based Segmentation of Residual Tumor in Histopathology of Pancreatic Cancer after Neoadjuvant TreatmentBoris V Janssen, Rutger Theijse, Stijn van Roessel, et al.
Journal of Hepatology|August 10, 2013
MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantationCornelia J Verhoeven, Waqar R R Farid, Petra E de Ruiter, et al.
Therapeutic Advances in Medical Oncology|June 18, 2019
Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatmentTessa Ya Sung Le Large, Btissame El Hassouni, Niccola Funel, et al.
Stem Cells and Development|March 30, 2012
Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomySuomi M G Fouraschen, Qiuwei Pan, Petra E de Ruiter, et al.
World Journal of Gastrointestinal Oncology|March 25, 2020
Clinical outcomes of patients with duodenal adenocarcinoma and intestinal-type papilla of Vater adenocarcinomaLaura L Meijer, Marin Strijker, Jacob K de Bakker, et al.
Annals of Surgery|February 2, 2023
Long-term Outcomes After Laparoscopic, Robotic, and Open Pancreatoduodenectomy for Distal Cholangiocarcinoma: An International Propensity Score-matched Cohort StudyBas A Uijterwijk, Daniël H L Lemmers, Louisa Bolm, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 20, 2024
Outcome of a 'step-up approach' for recurrent cholangitis in patients with a non-stenotic hepaticojejunostomy after hepato-pancreato-biliary surgery: single center seriesAlessandro M Bonomi, Anouk G Overdevest, Jeska A Fritzsche, et al.
Cancer Immunology, Immunotherapy : CII|November 8, 2023
Spatial immune composition of tumor microenvironment in patients with pancreatic cancerEline S Zwart, Thomas van Ee, Alsya J Affandi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2015
Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic CancerAnnette A van Zweeden, Hans J van der Vliet, Johanna W Wilmink, et al.
Pageof 30

Showing results (141-150 of 298) with videos related to

Sort By:
Pageof 30
Journal of Patient-Reported Outcomes|December 9, 2022
Development of a set of patient reported outcome measures for patients with benign liver tumours and cysts: patient focus groups and systematic reviewAlicia Furumaya, Lynn E Nooijen, Martijn P D Haring, et al.
Cancers|October 23, 2021
Artificial Intelligence-Based Segmentation of Residual Tumor in Histopathology of Pancreatic Cancer after Neoadjuvant TreatmentBoris V Janssen, Rutger Theijse, Stijn van Roessel, et al.
Journal of Hepatology|August 10, 2013
MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantationCornelia J Verhoeven, Waqar R R Farid, Petra E de Ruiter, et al.
Therapeutic Advances in Medical Oncology|June 18, 2019
Proteomic analysis of gemcitabine-resistant pancreatic cancer cells reveals that microtubule-associated protein 2 upregulation associates with taxane treatmentTessa Ya Sung Le Large, Btissame El Hassouni, Niccola Funel, et al.
Stem Cells and Development|March 30, 2012
Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomySuomi M G Fouraschen, Qiuwei Pan, Petra E de Ruiter, et al.
World Journal of Gastrointestinal Oncology|March 25, 2020
Clinical outcomes of patients with duodenal adenocarcinoma and intestinal-type papilla of Vater adenocarcinomaLaura L Meijer, Marin Strijker, Jacob K de Bakker, et al.
Annals of Surgery|February 2, 2023
Long-term Outcomes After Laparoscopic, Robotic, and Open Pancreatoduodenectomy for Distal Cholangiocarcinoma: An International Propensity Score-matched Cohort StudyBas A Uijterwijk, Daniël H L Lemmers, Louisa Bolm, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 20, 2024
Outcome of a 'step-up approach' for recurrent cholangitis in patients with a non-stenotic hepaticojejunostomy after hepato-pancreato-biliary surgery: single center seriesAlessandro M Bonomi, Anouk G Overdevest, Jeska A Fritzsche, et al.
Cancer Immunology, Immunotherapy : CII|November 8, 2023
Spatial immune composition of tumor microenvironment in patients with pancreatic cancerEline S Zwart, Thomas van Ee, Alsya J Affandi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2015
Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic CancerAnnette A van Zweeden, Hans J van der Vliet, Johanna W Wilmink, et al.
Pageof 30